-
Je něco špatně v tomto záznamu ?
Assessment of intellectual impairment, health-related quality of life, and behavioral phenotype in patients with neurotransmitter related disorders: Data from the iNTD registry
M. Keller, H. Brennenstuhl, O. Kuseyri Hübschmann, F. Manti, NA. Julia Palacios, J. Friedman, Y. Yıldız, JA. Koht, SN. Wong, DI. Zafeiriou, E. López-Laso, R. Pons, J. Kulhánek, K. Jeltsch, J. Serrano-Lomelin, SF. Garbade, T. Opladen, H. Goez,...
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Odkazy
PubMed
34245036
DOI
10.1002/jimd.12416
Knihovny.cz E-zdroje
- MeSH
- chování MeSH
- dítě MeSH
- dospělí MeSH
- fenotyp * MeSH
- inteligence MeSH
- internacionalita MeSH
- kognitivní dysfunkce etiologie MeSH
- kojenec MeSH
- kvalita života * MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- neurotransmiterové látky nedostatek MeSH
- předškolní dítě MeSH
- registrace MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Inherited disorders of neurotransmitter metabolism are a group of rare diseases, which are caused by impaired synthesis, transport, or degradation of neurotransmitters or cofactors and result in various degrees of delayed or impaired psychomotor development. To assess the effect of neurotransmitter deficiencies on intelligence, quality of life, and behavior, the data of 148 patients in the registry of the International Working Group on Neurotransmitter Related Disorders (iNTD) was evaluated using results from standardized age-adjusted tests and questionnaires. Patients with a primary disorder of monoamine metabolism had lower IQ scores (mean IQ 58, range 40-100) within the range of cognitive impairment (<70) compared to patients with a BH4 deficiency (mean IQ 84, range 40-129). Short attention span and distractibility were most frequently mentioned by parents, while patients reported most frequently anxiety and distractibility when asked for behavioral traits. In individuals with succinic semialdehyde dehydrogenase deficiency, self-stimulatory behaviors were commonly reported by parents, whereas in patients with dopamine transporter deficiency, DNAJC12 deficiency, and monoamine oxidase A deficiency, self-injurious or mutilating behaviors have commonly been observed. Phobic fears were increased in patients with 6-pyruvoyltetrahydropterin synthase deficiency, while individuals with sepiapterin reductase deficiency frequently experienced communication and sleep difficulties. Patients with BH4 deficiencies achieved significantly higher quality of life as compared to other groups. This analysis of the iNTD registry data highlights: (a) difference in IQ and subdomains of quality of life between BH4 deficiencies and primary neurotransmitter-related disorders and (b) previously underreported behavioral traits.
1st Department of Pediatrics Aristotle University of Thessaloniki Thessaloniki Greece
1st Department of Pediatrics of the University of Athens Aghia Sofia Hospital Athens Greece
Department of Neurology Oslo University Hospital Oslo Norway
Department of Neurology Washington University School of Medicine St Louis Missouri USA
Dietmar Hopp Metabolic Center University Children's Hospital Heidelberg Heidelberg Germany
UCSD Departments of Neuroscience and Pediatrics
University Children's Hospital St Josef Hospital Ruhr University Bochum Bochum Germany
Women and Children's Health Research Institute University of Alberta Edmonton Alberta Canada
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011997
- 003
- CZ-PrNML
- 005
- 20240627091612.0
- 007
- ta
- 008
- 220425s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/jimd.12416 $2 doi
- 035 __
- $a (PubMed)34245036
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Keller, Mareike $u Division of Child Neurology and Metabolic Medicine, University Children's Hospital Heidelberg, Heidelberg, Germany
- 245 10
- $a Assessment of intellectual impairment, health-related quality of life, and behavioral phenotype in patients with neurotransmitter related disorders: Data from the iNTD registry / $c M. Keller, H. Brennenstuhl, O. Kuseyri Hübschmann, F. Manti, NA. Julia Palacios, J. Friedman, Y. Yıldız, JA. Koht, SN. Wong, DI. Zafeiriou, E. López-Laso, R. Pons, J. Kulhánek, K. Jeltsch, J. Serrano-Lomelin, SF. Garbade, T. Opladen, H. Goez, International Working Group on Neurotransmitter related Disorders (iNTD), A. Burlina, E. Cortès-Saladelafont, JA. Fernández Ramos, A. García-Cazorla, GF. Hoffmann, ST. Kiat Hong, T. Honzík, I. Kavecan, MA. Kurian, V. Leuzzi, T. Lücke, F. Manzoni, M. Mastrangelo, S. Mercimek-Andrews, P. Mir, M. Oppebøen, TS. Pearson, HS. Sivri, D. Steel, G. Stevanović, CW. Fung
- 520 9_
- $a Inherited disorders of neurotransmitter metabolism are a group of rare diseases, which are caused by impaired synthesis, transport, or degradation of neurotransmitters or cofactors and result in various degrees of delayed or impaired psychomotor development. To assess the effect of neurotransmitter deficiencies on intelligence, quality of life, and behavior, the data of 148 patients in the registry of the International Working Group on Neurotransmitter Related Disorders (iNTD) was evaluated using results from standardized age-adjusted tests and questionnaires. Patients with a primary disorder of monoamine metabolism had lower IQ scores (mean IQ 58, range 40-100) within the range of cognitive impairment (<70) compared to patients with a BH4 deficiency (mean IQ 84, range 40-129). Short attention span and distractibility were most frequently mentioned by parents, while patients reported most frequently anxiety and distractibility when asked for behavioral traits. In individuals with succinic semialdehyde dehydrogenase deficiency, self-stimulatory behaviors were commonly reported by parents, whereas in patients with dopamine transporter deficiency, DNAJC12 deficiency, and monoamine oxidase A deficiency, self-injurious or mutilating behaviors have commonly been observed. Phobic fears were increased in patients with 6-pyruvoyltetrahydropterin synthase deficiency, while individuals with sepiapterin reductase deficiency frequently experienced communication and sleep difficulties. Patients with BH4 deficiencies achieved significantly higher quality of life as compared to other groups. This analysis of the iNTD registry data highlights: (a) difference in IQ and subdomains of quality of life between BH4 deficiencies and primary neurotransmitter-related disorders and (b) previously underreported behavioral traits.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a chování $7 D001519
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a kognitivní dysfunkce $x etiologie $7 D060825
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a inteligence $7 D007360
- 650 _2
- $a internacionalita $7 D038622
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a neurotransmiterové látky $x nedostatek $7 D018377
- 650 12
- $a fenotyp $7 D010641
- 650 12
- $a kvalita života $7 D011788
- 650 _2
- $a registrace $7 D012042
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Brennenstuhl, Heiko $u Division of Child Neurology and Metabolic Medicine, University Children's Hospital Heidelberg, Heidelberg, Germany $1 https://orcid.org/0000000269090003
- 700 1_
- $a Kuseyri Hübschmann, Oya $u Division of Child Neurology and Metabolic Medicine, University Children's Hospital Heidelberg, Heidelberg, Germany
- 700 1_
- $a Manti, Filippo $u Department of Human Neuroscience, Unit of Child Neurology and Psychiatry, Università degli Studi di Roma La Sapienza, Rome, Italy
- 700 1_
- $a Julia Palacios, Natalia Alexandra $u Inborn errors of metabolism Unit, Department of Neurology, Institut de Recerca Sant Joan de Déu and CIBERER-ISCIII, Barcelona, Spain
- 700 1_
- $a Friedman, Jennifer $u UCSD Departments of Neuroscience and Pediatrics; Rady Children's Hospital Division of Neurology, Rady Children's Institute for Genomic Medicine, San Diego, California, USA
- 700 1_
- $a Yıldız, Yılmaz $u Hacettepe University, Faculty of Medicine, Department of Pediatrics, Section of Pediatric Metabolism, Ankara, Turkey
- 700 1_
- $a Koht, Jeanette Aimee $u Department of Neurology, Oslo University Hospital, Oslo, Norway
- 700 1_
- $a Wong, Suet-Na $u Department of Pediatrics and Adolescent Medicine, The Hong Kong Children's Hospital, Hong Kong, Hong Kong
- 700 1_
- $a Zafeiriou, Dimitrios I $u First Department of Pediatrics Aristotle University of Thessaloniki, Thessaloniki, Greece
- 700 1_
- $a López-Laso, Eduardo $u Pediatric Neurology Unit, Department of Pediatrics, University Hospital Reina Sofía, IMIBIC and CIBERER, Córdoba, Spain
- 700 1_
- $a Pons, Roser $u First Department of Pediatrics of the University of Athens, Aghia Sofia Hospital, Athens, Greece
- 700 1_
- $a Kulhánek, Jan $u Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0319239
- 700 1_
- $a Jeltsch, Kathrin $u Division of Child Neurology and Metabolic Medicine, University Children's Hospital Heidelberg, Heidelberg, Germany
- 700 1_
- $a Serrano-Lomelin, Jesus $u Women and Children's Health Research Institute, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Garbade, Sven F $u Division of Child Neurology and Metabolic Medicine, University Children's Hospital Heidelberg, Heidelberg, Germany $u Dietmar-Hopp Metabolic Center, University Children's Hospital Heidelberg, Heidelberg, Germany
- 700 1_
- $a Opladen, Thomas $u Division of Child Neurology and Metabolic Medicine, University Children's Hospital Heidelberg, Heidelberg, Germany
- 700 1_
- $a Goez, Helly $u Department of Pediatrics, University of Alberta, Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada
- 700 1_
- $a Burlina, Alberto $u U.O.C. Malattie Metaboliche Ereditarie, Dipartimento della Salute della Donna e del Bambino, Azienda Ospedaliera Universitaria di Padova - Campus Biomedico Pietro d'Abano, Padova, Italy
- 700 1_
- $a Cortès-Saladelafont, Elisenda $u Inborn errors of metabolism Unit, Department of Neurology, Institut de Recerca Sant Joan de Déu and CIBERER-ISCIII, Barcelona, Spain $u Inborn Errors of Metabolism and Child Neurology Unit, Department of Pediatrics, Hospital Germans Trias i Pujol, Badalona and Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
- 700 1_
- $a Fernández Ramos, Joaquín Alejandro $u Pediatric Neurology Unit, Department of Pediatrics, University Hospital Reina Sofía, IMIBIC and CIBERER, Córdoba, Spain
- 700 1_
- $a García-Cazorla, Angeles $u Inborn errors of metabolism Unit, Department of Neurology, Institut de Recerca Sant Joan de Déu and CIBERER-ISCIII, Barcelona, Spain
- 700 1_
- $a Hoffmann, Georg F $u Division of Child Neurology and Metabolic Medicine, University Children's Hospital Heidelberg, Heidelberg, Germany
- 700 1_
- $a Kiat Hong, Stacey Tay $u KTP-National University Children's Medical Institute, National University Health System, Singapore, Singapore
- 700 1_
- $a Honzík, Tomáš $u Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Kavecan, Ivana $u Faculty of Medicine, University of Novi Sad, Institute for Children and Youth Health Care of Vojvodina, Novi Sad, Serbia
- 700 1_
- $a Kurian, Manju A $u Developmental Neurosciences, UCL Great Ormond Street-Institute of Child Health and Department of Neurology, Great Ormond Street Hospital, London, UK
- 700 1_
- $a Leuzzi, Vincenzo $u Department of Human Neuroscience, Unit of Child Neurology and Psychiatry, Università degli Studi di Roma La Sapienza, Rome, Italy
- 700 1_
- $a Lücke, Thomas $u University Children's Hospital, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany
- 700 1_
- $a Manzoni, Francesca $u U.O.C. Malattie Metaboliche Ereditarie, Dipartimento della Salute della Donna e del Bambino, Azienda Ospedaliera Universitaria di Padova - Campus Biomedico Pietro d'Abano, Padova, Italy
- 700 1_
- $a Mastrangelo, Mario $u Department of Human Neuroscience, Unit of Child Neurology and Psychiatry, Università degli Studi di Roma La Sapienza, Rome, Italy
- 700 1_
- $a Mercimek-Andrews, Saadet $u Division of Clinical and Metabolic Genetics, Department of Pediatrics, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada $u Department of Medical Genetics, University of Alberta, Women and Children's Health Research Institute, Stollery Children's Hospital, Edmonton, Alberta, Canada
- 700 1_
- $a Mir, Pablo $u Unidad de Trastornos del Movimiento Servicio de Neurología y Neurofisiología Clínica Unidad de Gestión Clínica de Neurociencias Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío, Sevilla, Spain
- 700 1_
- $a Oppebøen, Mari $u Children's Department Division of Child Neurology Oslo University Hospital Rikshospitalet, Oslo, Norway
- 700 1_
- $a Pearson, Toni S $u Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA
- 700 1_
- $a Sivri, H Serap $u Hacettepe University, Faculty of Medicine, Department of Pediatrics, Section of Pediatric Metabolism, Ankara, Turkey
- 700 1_
- $a Steel, Dora $u Developmental Neurosciences, UCL Great Ormond Street-Institute of Child Health and Department of Neurology, Great Ormond Street Hospital, London, UK
- 700 1_
- $a Stevanović, Galina $u Clinic of Neurology and Psychiatry for Children and Youth, School of Medicine, University of Belgrade, Belgrade, Serbia
- 700 1_
- $a Fung, Cheuk-Wing $u Department of Pediatrics and Adolescent Medicine, The Hong Kong Children's Hospital, Hong Kong, Hong Kong
- 710 2_
- $a International Working Group on Neurotransmitter related Disorders (iNTD)
- 773 0_
- $w MED00002747 $t Journal of inherited metabolic disease $x 1573-2665 $g Roč. 44, č. 6 (2021), s. 1489-1502
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34245036 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20240627091606 $b ABA008
- 999 __
- $a ok $b bmc $g 1789543 $s 1163198
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 44 $c 6 $d 1489-1502 $e 20210802 $i 1573-2665 $m Journal of inherited metabolic disease $n J Inherit Metab Dis $x MED00002747
- LZP __
- $a Pubmed-20220425
